Both in Lab Analytical Instruments
Precipio vs Harvard Bioscience
Over the past year PRPO returned +28.1% and HBIO returned +81.0%; their daily moves had a correlation of -0.08.
PRPO +28.1% HBIO +81.0%Growth of $1, one year, split-adjusted
| Metric | PRPO | HBIO |
|---|---|---|
| Price | $23.58 | $7.96 |
| Market cap | $42.2M | $36.2M |
| Today | −2.20% | −0.25% |
| 1 month | −18.3% | +0.4% |
| 6 months | −1.3% | +70.8% |
| Year to date | +2.6% | +19.0% |
| 1 year | +35.4% | +79.3% |
| Revenue growth (YoY) | +24.7% | +11.1% |
| Gross margin | 44.7% | 55.6% |
| Net margin | −3.1% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 0.4× |
| Net cash | $1.9M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 39.6% |
| Short % of float | 4.5% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).